First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty

Mark T. Nolan; Louise Creati; Bogda Koczwara; Leonard Kritharides; James Lynam; Alexander R. Lyon; Kazuaki Negishi; Doan T.M. Ngo; Liza Thomas; Janette Vardy; Aaron L. Sverdlov

doi:10.1016/j.hlc.2022.11.003

First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty

Mark T. Nolan, Louise Creati, Bogda Koczwara, Leonard Kritharides, James Lynam, Alexander R. Lyon, Kazuaki Negishi, Doan T.M. Ngo, Liza Thomas, Janette Vardy, Aaron L. Sverdlov

College of Medicine and Public Health

Research output: Contribution to journal › Editorial

Abstract

The recent release of the European Society of Cardiology’s Cardio-Oncology guidelines represents a substantial and significant body of scholarly work [1]. These are the first cardio-oncology guidelines to be published by a large multi-national cardiovascular professional society (in collaboration with the European Haematology Association and European Society for Therapeutic Radiology and Oncology) and also the first guidelines to be produced through joint partnership between cardiology and oncology multinational associations. Developed over 2 years by an accomplished and diverse team, the comprehensive guidelines consist of 133 pages and contain 50 tables, 48 figures and 837 references with 271 new recommendations. Cardio-toxicity monitoring protocols for 18 classes of anti-cancer treatments are discussed in detail and many aspects of cardiovascular pathology, from valvular diseases to arrhythmia to cardiomyopathic conditions, are considered. This breadth of information confirms what several thought leaders in cardiology have previously advocated [2]: cardio-oncology has expanded beyond being a facet of general cardiology and is now unquestionably an independent subspecialty that merits recognition and its own accredited training programs with oversight and formalised governance by appropriate professional associations.

Original language	English
Pages (from-to)	1563-1567
Number of pages	5
Journal	Heart Lung and Circulation
Volume	31
Issue number	12
DOIs	https://doi.org/10.1016/j.hlc.2022.11.003
Publication status	Published - Dec 2022

Keywords

Cardio-oncology
Editorial
Guidelines

Access to Document

10.1016/j.hlc.2022.11.003Licence: In Copyright

Cite this

@article{87569430fb5a437c931d46d2155062ad,

title = "First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty",

abstract = "The recent release of the European Society of Cardiology{\textquoteright}s Cardio-Oncology guidelines represents a substantial and significant body of scholarly work [1]. These are the first cardio-oncology guidelines to be published by a large multi-national cardiovascular professional society (in collaboration with the European Haematology Association and European Society for Therapeutic Radiology and Oncology) and also the first guidelines to be produced through joint partnership between cardiology and oncology multinational associations. Developed over 2 years by an accomplished and diverse team, the comprehensive guidelines consist of 133 pages and contain 50 tables, 48 figures and 837 references with 271 new recommendations. Cardio-toxicity monitoring protocols for 18 classes of anti-cancer treatments are discussed in detail and many aspects of cardiovascular pathology, from valvular diseases to arrhythmia to cardiomyopathic conditions, are considered. This breadth of information confirms what several thought leaders in cardiology have previously advocated [2]: cardio-oncology has expanded beyond being a facet of general cardiology and is now unquestionably an independent subspecialty that merits recognition and its own accredited training programs with oversight and formalised governance by appropriate professional associations.",

keywords = "Cardio-oncology, Editorial, Guidelines",

author = "Nolan, {Mark T.} and Louise Creati and Bogda Koczwara and Leonard Kritharides and James Lynam and Lyon, {Alexander R.} and Kazuaki Negishi and Ngo, {Doan T.M.} and Liza Thomas and Janette Vardy and Sverdlov, {Aaron L.}",

year = "2022",

month = dec,

doi = "10.1016/j.hlc.2022.11.003",

language = "English",

volume = "31",

pages = "1563--1567",

journal = "Heart, Lung and Circulation",

issn = "1443-9506",

publisher = "Science Direct",

number = "12",

}

TY - JOUR

T1 - First European Society of Cardiology Cardio-Oncology Guidelines

T2 - A Big Leap Forward for an Emerging Specialty

AU - Nolan, Mark T.

AU - Creati, Louise

AU - Koczwara, Bogda

AU - Kritharides, Leonard

AU - Lynam, James

AU - Lyon, Alexander R.

AU - Negishi, Kazuaki

AU - Ngo, Doan T.M.

AU - Thomas, Liza

AU - Vardy, Janette

AU - Sverdlov, Aaron L.

PY - 2022/12

Y1 - 2022/12

N2 - The recent release of the European Society of Cardiology’s Cardio-Oncology guidelines represents a substantial and significant body of scholarly work [1]. These are the first cardio-oncology guidelines to be published by a large multi-national cardiovascular professional society (in collaboration with the European Haematology Association and European Society for Therapeutic Radiology and Oncology) and also the first guidelines to be produced through joint partnership between cardiology and oncology multinational associations. Developed over 2 years by an accomplished and diverse team, the comprehensive guidelines consist of 133 pages and contain 50 tables, 48 figures and 837 references with 271 new recommendations. Cardio-toxicity monitoring protocols for 18 classes of anti-cancer treatments are discussed in detail and many aspects of cardiovascular pathology, from valvular diseases to arrhythmia to cardiomyopathic conditions, are considered. This breadth of information confirms what several thought leaders in cardiology have previously advocated [2]: cardio-oncology has expanded beyond being a facet of general cardiology and is now unquestionably an independent subspecialty that merits recognition and its own accredited training programs with oversight and formalised governance by appropriate professional associations.

AB - The recent release of the European Society of Cardiology’s Cardio-Oncology guidelines represents a substantial and significant body of scholarly work [1]. These are the first cardio-oncology guidelines to be published by a large multi-national cardiovascular professional society (in collaboration with the European Haematology Association and European Society for Therapeutic Radiology and Oncology) and also the first guidelines to be produced through joint partnership between cardiology and oncology multinational associations. Developed over 2 years by an accomplished and diverse team, the comprehensive guidelines consist of 133 pages and contain 50 tables, 48 figures and 837 references with 271 new recommendations. Cardio-toxicity monitoring protocols for 18 classes of anti-cancer treatments are discussed in detail and many aspects of cardiovascular pathology, from valvular diseases to arrhythmia to cardiomyopathic conditions, are considered. This breadth of information confirms what several thought leaders in cardiology have previously advocated [2]: cardio-oncology has expanded beyond being a facet of general cardiology and is now unquestionably an independent subspecialty that merits recognition and its own accredited training programs with oversight and formalised governance by appropriate professional associations.

KW - Cardio-oncology

KW - Editorial

KW - Guidelines

UR - http://www.scopus.com/inward/record.url?scp=85144481079&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2022.11.003

DO - 10.1016/j.hlc.2022.11.003

M3 - Editorial

C2 - 36549840

AN - SCOPUS:85144481079

VL - 31

SP - 1563

EP - 1567

JO - Heart, Lung and Circulation

JF - Heart, Lung and Circulation

SN - 1443-9506

IS - 12

ER -

First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this